The isoprostanes in biology and medicine

被引:160
作者
Praticò, D
Lawson, JA
Rokach, J
FitzGerald, GA
机构
[1] Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA
[2] Florida Inst Technol, Dept Chem, Claude Pepper Inst, Melbourne, FL 32901 USA
关键词
D O I
10.1016/S1043-2760(01)00411-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Isoprostanes are a new class of lipids, isomers of the conventional enzymatically derived prostaglandins, which are produced in vivo primarily by a free radical-catalyzed peroxidation of polyunsaturated fatty acids. F-2-isoprostanes, isomers of the enzyme-derived prostaglandin F-2 alpha, are the most studied species, but analogous isomers of other prostaglandins and leukotrienes have been described. Because of their mechanism of formation, specific structural features that distinguish them from other free radical-generated products and chemical stability, they can provide a reliable index for the oxidant component of several diseases in vivo. Consistent data suggest that formation of F-2-isoprostanes is altered in a variety of clinical settings putatively associated with oxidant stress. Moreover, measurement of F-2-isoprostanes might provide a sensitive biochemical basis for dose-selection in studies of natural and synthetic antioxidants. Finally, some F-2-isoprostanes possess potent biological activities in vitro and in vivo, suggesting that they may also act as mediators of the cellular effects of oxidative stress.
引用
收藏
页码:243 / 247
页数:5
相关论文
共 65 条
[1]   Total synthesis of a novel isoprostane IPF2 alpha-I and its identification in biological fluids [J].
Adiyaman, M ;
Lawson, JA ;
Hwang, SW ;
Khanapure, SP ;
FitzGerald, GA ;
Rokach, J .
TETRAHEDRON LETTERS, 1996, 37 (28) :4849-4852
[2]   Cardiovascular responses to the isoprostanes iPF2α-III and iPE2-III are mediated via the thromboxane A2 receptor in vivo [J].
Audoly, LP ;
Rocca, B ;
Fabre, JE ;
Koller, BH ;
Thomas, D ;
Loeb, AL ;
Coffman, TM ;
FitzGerald, GA .
CIRCULATION, 2000, 101 (24) :2833-2840
[3]   Measurement of urinary 8-epi-prostaglandin F-2 alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction gas chromatography mass spectrometry. Basal levels in smokers and nonsmokers [J].
Bachi, A ;
Zuccato, E ;
Baraldi, M ;
Fanelli, R ;
Chiabrando, C .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (04) :619-624
[4]   EFFECTS OF A NOVEL PROSTAGLANDIN, 8-EPI-PGF2-ALPHA, IN RABBIT LUNG INSITU [J].
BANERJEE, M ;
KANG, KH ;
MORROW, JD ;
ROBERTS, LJ ;
NEWMAN, JH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03) :H660-H663
[5]   Mouse models of atherosclerosis [J].
Breslow, JL .
SCIENCE, 1996, 272 (5262) :685-688
[6]   THE NEUROBIOLOGICAL CONSEQUENCES OF DOWN-SYNDROME [J].
COYLE, JT ;
OSTERGRANITE, ML ;
GEARHART, JD .
BRAIN RESEARCH BULLETIN, 1986, 16 (06) :773-787
[7]  
Davì G, 1999, CIRCULATION, V99, P224
[8]   Oxidative injury in the nervous system [J].
Delanty, N ;
Dichter, MA .
ACTA NEUROLOGICA SCANDINAVICA, 1998, 98 (03) :145-153
[9]   8-Epi PGF(2 alpha) generation during coronary reperfusion - A potential quantitative marker of oxidant stress in vivo [J].
Delanty, N ;
Reilly, MP ;
Pratico, D ;
Lawson, JA ;
McCarthy, JF ;
Wood, AE ;
Ohnishi, ST ;
Fitzgerald, DJ ;
FitzGerald, GA .
CIRCULATION, 1997, 95 (11) :2492-2499
[10]   FORMATION OF PGF(2)-ISOPROSTANES DURING THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN [J].
GOPAUL, NK ;
NOUROOZZADEH, J ;
MALLET, AI ;
ANGGARD, EE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (01) :338-343